This manuscript was withdrawn by the author.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1074/jbc.M111.276048 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells.
Clin Cancer Res
January 2024
EnGeneIC Ltd., Sydney, New South Wales, Australia.
Article Synopsis
- The study evaluated a new EGFR-targeted drug, E-EDV-D682/GC, in patients with advanced pancreatic ductal adenocarcinoma (PDAC) who had no other treatment options.
- Conducted as a phase I/IIa clinical trial, it focused on safety and overall survival, showing that most patients experienced only mild side effects and there were no serious safety concerns.
- The median overall survival was 4.4 months for all patients, but those who completed a treatment cycle had a better outcome of 6.9 months, indicating potential effectiveness of the treatment.
FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer's disease expressing APOE4.
Biomed Pharmacother
August 2022
Maastricht University, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht 6200MD, the Netherlands. Electronic address:
The protection mediated by the bioactive sphingolipid sphingosine-1-phosphate (S1P) declines during Alzheimer's disease (AD) progression, especially in patients carrying the apolipoprotein E ε4 (APOE4) isoform. The drug FTY720 mimics S1P bioactivity, but its efficacy in treating AD is unclear. Two doses of FTY720 (0.
View Article and Find Full Text PDFCeramide accumulation accelerates nucleus pulposus cells degradation by p38MAPK activation.
Eur Rev Med Pharmacol Sci
August 2021
Department of Orthopedics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
The article "Ceramide accumulation accelerates nucleus pulposus cells degradation by p38MAPK activation, by W.-J. Wu, J.
View Article and Find Full Text PDFWITHDRAWN: Ceramide and Sphingosine 1-Phosphate in adipose dysfunction.
Prog Lipid Res
August 2019
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161, Cathedral St, Glasgow, G4 0RE, Scotland, UK.
WITHDRAWN: Ceramide synthases in cancer therapy and chemoresistance.
Prog Lipid Res
August 2019
Institute of Clinical Pharmacology, Faculty of Medicine, Goethe University Frankfurt, Theodor-Stern Kai 7, Frankfurt 60590, Germany.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!